Department of Medical Radiation Physics, Karolinska Institutet, Stockholm University, Sweden.
Br J Radiol. 2011 Feb;84(998):161-72. doi: 10.1259/bjr/89275085. Epub 2010 Sep 21.
The aim of this study was to compare three-dimensional (3D) conformal radiotherapy and the two different forms of IMRT in lung cancer radiotherapy.
Cases of four lung cancer patients were investigated by developing a 3D conformal treatment plan, a linac MLC-based step-and-shoot IMRT plan and an HT plan for each case. With the use of the complication-free tumour control probability (P(+)) index and the uniform dose concept as the common prescription point of the plans, the different treatment plans were compared based on radiobiological measures.
The applied plan evaluation method shows the MLC-based IMRT and the HT treatment plans are almost equivalent over the clinically useful dose prescription range; however, the 3D conformal plan inferior. At the optimal dose levels, the 3D conformal treatment plans give an average P(+) of 48.1% for a effective uniform dose to the internal target volume (ITV) of 62.4 Gy, whereas the corresponding MLC-based IMRT treatment plans are more effective by an average ΔP(+) of 27.0% for a Δ effective uniform dose of 16.3 Gy. Similarly, the HT treatment plans are more effective than the 3D-conformal plans by an average ΔP(+) of 23.8% for a Δ effective uniform dose of 11.6 Gy.
A radiobiological treatment plan evaluation can provide a closer association of the delivered treatment with the clinical outcome by taking into account the dose-response relations of the irradiated tumours and normal tissues. The use of P - effective uniform dose diagrams can complement the traditional tools of evaluation to compare and effectively evaluate different treatment plans.
本研究旨在比较三维适形放疗和两种不同形式的调强放疗在肺癌放疗中的应用。
对 4 例肺癌患者进行研究,为每个病例制定 3D 适形治疗计划、基于直线加速器多叶准直器的步进式调强放疗计划和 HT 计划。利用无并发症肿瘤控制概率(P(+))指数和均匀剂量概念作为计划的共同处方点,基于放射生物学指标对不同治疗计划进行比较。
所应用的计划评估方法表明,在临床有用的剂量处方范围内,基于多叶准直器的调强放疗和 HT 治疗计划几乎等效;然而,3D 适形计划则稍差。在最佳剂量水平下,3D 适形治疗计划使内部靶区(ITV)的有效均匀剂量达到 62.4Gy 时的平均 P(+)为 48.1%,而相应的基于多叶准直器的调强放疗计划则更有效,平均ΔP(+)为 27.0%,Δ有效均匀剂量为 16.3Gy。同样,HT 治疗计划比 3D 适形计划更有效,平均ΔP(+)为 23.8%,Δ有效均匀剂量为 11.6Gy。
通过考虑照射肿瘤和正常组织的剂量反应关系,放射生物学治疗计划评估可以更密切地将所提供的治疗与临床结果联系起来。使用 P-有效均匀剂量图可以补充传统的评估工具,以比较和有效地评估不同的治疗计划。